[go: up one dir, main page]

MX2010004353A - Combinación anticonceptiva oral entiemética. - Google Patents

Combinación anticonceptiva oral entiemética.

Info

Publication number
MX2010004353A
MX2010004353A MX2010004353A MX2010004353A MX2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A
Authority
MX
Mexico
Prior art keywords
antiemetic
oral contraceptive
contraceptive combination
combination
contraceptive formulation
Prior art date
Application number
MX2010004353A
Other languages
English (en)
Inventor
Sheetal Kulkarni
Srirupa Das
Harshal Anil Jahagirdar
Satish Dalal
Shirish Kulkarni
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of MX2010004353A publication Critical patent/MX2010004353A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con un método para reducir la incidencia de náuseas y vómito asociados con la administración de una formulación anticonceptiva oral que contienen progestina y/o estrógeno y un antiemético. La formulación anticonceptiva oral preferida está constituida por levonorgestrel y un antiemético.
MX2010004353A 2007-10-25 2008-10-24 Combinación anticonceptiva oral entiemética. MX2010004353A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1460KO2007 2007-10-25
PCT/IN2008/000704 WO2009054007A1 (en) 2007-10-25 2008-10-24 Antiemetic-oral contraceptive combination

Publications (1)

Publication Number Publication Date
MX2010004353A true MX2010004353A (es) 2010-07-06

Family

ID=40343574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004353A MX2010004353A (es) 2007-10-25 2008-10-24 Combinación anticonceptiva oral entiemética.

Country Status (8)

Country Link
US (1) US8507465B2 (es)
EP (1) EP2211866A1 (es)
JP (1) JP2011500793A (es)
AU (1) AU2008315319A1 (es)
BR (1) BRPI0818852A2 (es)
MX (1) MX2010004353A (es)
WO (1) WO2009054007A1 (es)
ZA (1) ZA201003697B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010007629A1 (en) * 2008-07-15 2010-01-21 Lupin Limited A kit comprising anti-emetic and oral contraceptive
DE102011051308A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Herstellungsverfahren und Arzneiform
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN118384121B (zh) * 2024-06-24 2024-10-15 广州朗圣药业有限公司 左炔诺孕酮肠溶片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2558297A (en) * 1996-05-16 1997-12-05 Gynetics Inc. Emergency contraceptive kit
CA2354250A1 (en) 2001-07-27 2003-01-27 Mario Hannouche Use of h1 histamine receptor antagonists for the prevention or attenuation of side effects associated with high doses of female hormones
CN1485093A (zh) 2003-08-22 2004-03-31 广州贝氏药业有限公司 复方避孕药灭吐灵制剂

Also Published As

Publication number Publication date
WO2009054007A1 (en) 2009-04-30
BRPI0818852A2 (pt) 2015-04-14
AU2008315319A1 (en) 2009-04-30
ZA201003697B (en) 2011-03-30
US8507465B2 (en) 2013-08-13
US20100240626A1 (en) 2010-09-23
EP2211866A1 (en) 2010-08-04
JP2011500793A (ja) 2011-01-06

Similar Documents

Publication Publication Date Title
MX2010004353A (es) Combinación anticonceptiva oral entiemética.
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
NZ615430A (en) Method for on-demand contraception
MY169516A (en) Pharmaceutical composition containing a tetrahydrofolic acid
TW200603813A (en) Cyclic progestin regimens and kits
MX2007000273A (es) Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona.
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
WO2011066260A3 (en) Formulations comprising aminosterols
EP4335501A3 (en) Use of estriol in low doses
BR112012007412A2 (pt) tabletes transformáveis de forma oral.
ZA201008372B (en) Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
DK1361881T3 (da) Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
CR10259A (es) Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local
TW200605880A (en) Progesterone receptor antagonist contraceptive regimens and kits
AU2010293105A8 (en) Oral suspension formulations of esclicarbazepine acetate
WO2008113901A3 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
MX2010005198A (es) Composiciones liquidas que comprenden valsartan.
AR065816A1 (es) Regimen anticonceptivo oral
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
MA33022B1 (fr) Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil
PE20090805A1 (es) COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL

Legal Events

Date Code Title Description
FG Grant or registration